ExpertiseUpdated on 17 February 2026
CMC Leadership for Biologics: From Concept to Commercial Manufacturing
About
We offer hands-on CMC leadership to take biologic programs from concept through Phase I and into commercial manufacturing. The focus is practical execution: designing a manufacturable process early, building the right analytics and potency logic, and scaling with disciplined tech transfer and quality systems.
We can support partners with:
-
End-to-end CMC strategy and stage-appropriate execution plans
-
Process concept, development, scale-up, and manufacturability decisions
-
Analytical strategy, potency, and control strategy aligned with clinical and commercial needs
-
Tech transfer packages and oversight across internal teams and CDMOs
-
GMP readiness, comparability thinking, and risk management to avoid late surprises
If you need a CMC-led execution partner who turns science into a robust, scalable manufacturing path, I’d welcome a conversation.
Field
- Biotech, Pharma and Cosmetics
Organisation
Similar opportunities
Partnership
EU GMP Clinical Manufacturing Partner for Phase I Supply
Ramtin Rahbar
Co-founder and Chief Technical Officer at Ness Therapeutics
Toronto, Canada
Project cooperation
EU work packages to accelerate Phase I readiness
- Execution
- Technical
- Biotech, Pharma and Cosmetics
Ramtin Rahbar
Co-founder and Chief Technical Officer at Ness Therapeutics
Toronto, Canada
Expertise
Clinical Operations and Project Manager/Clinical Trial & Data Manager
- Healthcare
- Biotech, Pharma and Cosmetics
Madhuparna Ganguly
Clinical Operations & Project Manager | MBA candidate at Swiss Tropical and Public Health Institute
Zurich, Switzerland